Constellation Pharmaceuticals initiated at Baird
Constellation Pharmaceuticals initiated with an Outperform at Baird. Baird analyst Michael Utz initialed Constellation Pharmaceuticals with an Outperform and $17 price target.https://thefly.com/landingPageNews.php?id=2854741
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.